Advertising

SPDR Health Care E.T.F.

XLV-N

NYSEARCA:XLV

133.00
0.13 (0.10%)

Analysis and Opinions about XLV-N

Signal
Opinion
Expert
Chart
BUY
BUY
June 24, 2021
Long-term, really likes the sector. When things are hot, the sector may lag. XLV has about 65 names. Aging demographics, growing emerging markets and middle class, increased healthcare spending. This year, healthcare ranks #8 out of 11 sectors. But if you're concerned about the long term, which he thinks you should be, XLV is a good place to start.
Show full opinionHide full opinion
Long-term, really likes the sector. When things are hot, the sector may lag. XLV has about 65 names. Aging demographics, growing emerging markets and middle class, increased healthcare spending. This year, healthcare ranks #8 out of 11 sectors. But if you're concerned about the long term, which he thinks you should be, XLV is a good place to start.
Stan Wong
Price
$125.365
Owned
Unknown
DON'T BUY
DON'T BUY
May 25, 2021

Better to buy the holdings? He doesn't buy ETFs, because he's an active manager. He'd rather buy the individual stocks, and he doesn't know what's in this ETF, though Thermo-Fisher, a key holding, is a fine company. In this sector, he owns Anthem, Abbvie and CVS, for example. Healthcare isn't in the sun now, but you can do well if you pick the right stocks.

Show full opinionHide full opinion

Better to buy the holdings? He doesn't buy ETFs, because he's an active manager. He'd rather buy the individual stocks, and he doesn't know what's in this ETF, though Thermo-Fisher, a key holding, is a fine company. In this sector, he owns Anthem, Abbvie and CVS, for example. Healthcare isn't in the sun now, but you can do well if you pick the right stocks.

Gordon Reid
Price
$124.110
Owned
No
TOP PICK
TOP PICK
May 5, 2021
There's been talk of change of the US healthcare system for years, but Covid is making it difficult to do that right now and makes healthcare protected from attack. Strong seasonal period right now. Elective surgeries coming back. Huge opportunity for an uptick at least until August. Yield is 1.39%.
Show full opinionHide full opinion
There's been talk of change of the US healthcare system for years, but Covid is making it difficult to do that right now and makes healthcare protected from attack. Strong seasonal period right now. Elective surgeries coming back. Huge opportunity for an uptick at least until August. Yield is 1.39%.
Brooke Thackray
Price
$123.250
Owned
Yes
PAST TOP PICK
PAST TOP PICK
August 5, 2020
(A Top Pick May 07/20, Up 8%) Healthcare sector is a bit exhausted right now, and seeing relative weakness. He's walked back from it a bit. Coming up to an election, healthcare can become a political football.
Show full opinionHide full opinion
(A Top Pick May 07/20, Up 8%) Healthcare sector is a bit exhausted right now, and seeing relative weakness. He's walked back from it a bit. Coming up to an election, healthcare can become a political football.
Brooke Thackray
Price
$106.550
Owned
Yes
TOP PICK
TOP PICK
May 7, 2020
The healthcare sector has outperformed the S&P since February. There is a lot of money going into this sector. It tends to do well this time of year also. We also have to be more cautious in election years but it will be harder for this sector to be kicked back and forth like a football.
Show full opinionHide full opinion
The healthcare sector has outperformed the S&P since February. There is a lot of money going into this sector. It tends to do well this time of year also. We also have to be more cautious in election years but it will be harder for this sector to be kicked back and forth like a football.
Brooke Thackray
Price
$98.900
Owned
Yes
PAST TOP PICK
PAST TOP PICK
September 24, 2019
(A Top Pick May 09/19, Up 4%) Seasonality ends Oct. 24. It's been faltering lately. The US election campaign is a headwind and will continue to overhang. He may exit this.
Show full opinionHide full opinion
(A Top Pick May 09/19, Up 4%) Seasonality ends Oct. 24. It's been faltering lately. The US election campaign is a headwind and will continue to overhang. He may exit this.
Brooke Thackray
Price
$90.670
Owned
Yes
PAST TOP PICK
PAST TOP PICK
September 11, 2019
(A Top Pick Sep 12/18, Down 1%) He was stopped out of this. The medical devices space is good. Biotech services, are under huge pressure. This ETF was a little too inclusive so he exited.
Show full opinionHide full opinion
(A Top Pick Sep 12/18, Down 1%) He was stopped out of this. The medical devices space is good. Biotech services, are under huge pressure. This ETF was a little too inclusive so he exited.
Cameron Hurst
Price
$91.590
Owned
No
COMMENT
COMMENT
September 6, 2019

US Healthcare For knee replacements and implants he likes SNN-N. He does not prefer the ETFs, such as XLV-N, because they hold too broad of an array of companies, including the big drug companies that are under pressure. He would focus on the tool and device space instead.

Show full opinionHide full opinion

US Healthcare For knee replacements and implants he likes SNN-N. He does not prefer the ETFs, such as XLV-N, because they hold too broad of an array of companies, including the big drug companies that are under pressure. He would focus on the tool and device space instead.

Darren Sissons
Price
$91.270
Owned
_N/A
PAST TOP PICK
PAST TOP PICK
August 7, 2019
(A Top Pick Aug 07/18, Up 1%) He was stopped out a while ago. Managed care got hit and became politicized. The sector went neutral, so he went into medical devices instead.
Show full opinionHide full opinion
(A Top Pick Aug 07/18, Up 1%) He was stopped out a while ago. Managed care got hit and became politicized. The sector went neutral, so he went into medical devices instead.
Cameron Hurst
Price
$90.090
Owned
No
TOP PICK
TOP PICK
May 9, 2019
It is defensive with a seasonal period from May first to the beginning of August. Investors get attracted to this sector at this time of the year because it is defensive. It has started to outperform the market. It is less exposed to the China/US trade deal. It is not a bad place to be. It is a place to hide out in.
Show full opinionHide full opinion
It is defensive with a seasonal period from May first to the beginning of August. Investors get attracted to this sector at this time of the year because it is defensive. It has started to outperform the market. It is less exposed to the China/US trade deal. It is not a bad place to be. It is a place to hide out in.
TOP PICK
TOP PICK
January 8, 2019
Buying beta. Can drop with the market but high quality market exposure. Tends to have high cash flow, large cap, robust companies, well diversified. Yield 1.6%.
Show full opinionHide full opinion
Buying beta. Can drop with the market but high quality market exposure. Tends to have high cash flow, large cap, robust companies, well diversified. Yield 1.6%.
Cameron Hurst
Price
$86.960
Owned
Yes
TOP PICK
TOP PICK
December 6, 2018
You want to focus your portfolio on leadership. He likes healthcare late cycle. These tend to have a higher cap. This is the largest diversified exposure in his portfolio.
Show full opinionHide full opinion
You want to focus your portfolio on leadership. He likes healthcare late cycle. These tend to have a higher cap. This is the largest diversified exposure in his portfolio.
Cameron Hurst
Price
$92.890
Owned
Yes
TOP PICK
TOP PICK
October 15, 2018

It's the largest by far in this space and cheap at 0.13% MER. Carries the biggies in healthcare with J&J, Pfizer as the top two holdings. It's highly liquid. He wants US dollars now, which is another plus. Also likes ZUB-T, but he prefers U.S. dollars.

Show full opinionHide full opinion

It's the largest by far in this space and cheap at 0.13% MER. Carries the biggies in healthcare with J&J, Pfizer as the top two holdings. It's highly liquid. He wants US dollars now, which is another plus. Also likes ZUB-T, but he prefers U.S. dollars.

John Hood
Price
$90.440
Owned
Yes
TOP PICK
TOP PICK
September 12, 2018

He feels the market is near the late stages of the bull run, but feels this balanced portfolio will continue to work well.

Show full opinionHide full opinion

He feels the market is near the late stages of the bull run, but feels this balanced portfolio will continue to work well.

Cameron Hurst
Price
$92.690
Owned
Yes
TOP PICK
TOP PICK
August 7, 2018

This tends to be late stage and has been growing rapidly in the last 3-to-4 months. It is just starting to break out. Within the underlying sector, more industries are starting to do well pharma, services, distributors and hospitals are all improving and the US-based policy risk seems to be toning down. (Analysts’ price target was not provided)

Show full opinionHide full opinion

This tends to be late stage and has been growing rapidly in the last 3-to-4 months. It is just starting to break out. Within the underlying sector, more industries are starting to do well pharma, services, distributors and hospitals are all improving and the US-based policy risk seems to be toning down. (Analysts’ price target was not provided)

Cameron Hurst
Price
$89.980
Owned
Yes
Showing 1 to 15 of 36 entries

SPDR Health Care E.T.F.(XLV-N) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 2

Stockchase rating for SPDR Health Care E.T.F. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

SPDR Health Care E.T.F.(XLV-N) Frequently Asked Questions

What is SPDR Health Care E.T.F. stock symbol?

SPDR Health Care E.T.F. is a American stock, trading under the symbol XLV-N on the NYSE Arca (XLV). It is usually referred to as AMEX:XLV or XLV-N

Is SPDR Health Care E.T.F. a buy or a sell?

In the last year, 2 stock analysts published opinions about XLV-N. 1 analyst recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for SPDR Health Care E.T.F..

Is SPDR Health Care E.T.F. a good investment or a top pick?

SPDR Health Care E.T.F. was recommended as a Top Pick by Stan Wong on 2021-06-24. Read the latest stock experts ratings for SPDR Health Care E.T.F..

Why is SPDR Health Care E.T.F. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is SPDR Health Care E.T.F. worth watching?

2 stock analysts on Stockchase covered SPDR Health Care E.T.F. In the last year. It is a trending stock that is worth watching.

What is SPDR Health Care E.T.F. stock price?

On 2021-09-17, SPDR Health Care E.T.F. (XLV-N) stock closed at a price of $133.